Reduced expression of the mRNAs for the ADCY5, EVX1, GFRA1 and PDE9A genes was significantly correlated with clinicopathological parameters (Table 2), indicating that DNA methylation alterations, even from the precancerous stage, ultimately determine the tumor phenotype through gene silencing. This evidence concerns the gene EVX1 and neoplasm.